Studies assessing the association of ELN response and thrombosis or survival
| Study . | Disease . | N . | Treatment . | Association with ELN complete response . | |
|---|---|---|---|---|---|
| Thrombosis . | Survival . | ||||
| Hernandez-Boluda et al48 | ET | 134 | HU | No | No |
| Hernandez-Boluda et al49 | ET | 154 | Anagrelide | No | No |
| Alvarez-Larrán et al50 | PV | 261 | HU | No | No |
| Tremblay et al51 | PV | 398 | HU PEG-IFN Ruxolitinib | No | No |
| Study . | Disease . | N . | Treatment . | Association with ELN complete response . | |
|---|---|---|---|---|---|
| Thrombosis . | Survival . | ||||
| Hernandez-Boluda et al48 | ET | 134 | HU | No | No |
| Hernandez-Boluda et al49 | ET | 154 | Anagrelide | No | No |
| Alvarez-Larrán et al50 | PV | 261 | HU | No | No |
| Tremblay et al51 | PV | 398 | HU PEG-IFN Ruxolitinib | No | No |